|
3
|
11
|
8b94C |
Crystal structure of pparg and ncor2 with bay-5516, an inverse agonist |
|
3
|
12
|
8b8xC |
Crystal structure of pparg and ncor2 with sr10221, an inverse agonist |
|
4
|
11
|
8b8yC |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7e) |
|
4
|
12
|
8b8wC |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7a) |
|
101
|
273
|
8b8xA |
Crystal structure of pparg and ncor2 with sr10221, an inverse agonist |
|
89
|
260
|
8b93A |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 15b) |
|
99
|
270
|
8b94A |
Crystal structure of pparg and ncor2 with bay-5516, an inverse agonist |
|
96
|
260
|
8b92A |
Crystal structure of pparg and ncor2 with an inverse agonist (compound si-2) |
|
100
|
273
|
8b8wA |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7a) |
|
4
|
11
|
8b8zC |
Crystal structure of mutant pparg (c313a) and ncor2 with an inverse agonist (compound 7e) |
|
96
|
271
|
8b8zA |
Crystal structure of mutant pparg (c313a) and ncor2 with an inverse agonist (compound 7e) |
|
98
|
271
|
8b8yA |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7e) |
|
3
|
11
|
8b90C |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7d) |
|
4
|
13
|
8aqmC |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 6a) |
|
101
|
276
|
8aqmA |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 6a) |
|
109
|
276
|
8aqnA |
Crystal structure of pparg and ncor2 with bay-4931, an inverse agonist (compound 6c) |
|
6
|
21
|
8aqnC |
Crystal structure of pparg and ncor2 with bay-4931, an inverse agonist (compound 6c) |
|
94
|
272
|
8dkvA |
Pparg bound to jtp-426467 and co-r peptide |
|
87
|
267
|
8dsyA |
Pparg bound to inverse agonist h3b-343 |
|
4
|
14
|
8dkvC |
Pparg bound to jtp-426467 and co-r peptide |
|
3
|
13
|
8dknC |
Pparg bound to t0070907 and co-r peptide |
|
95
|
272
|
8dknA |
Pparg bound to t0070907 and co-r peptide |
|
93
|
268
|
8dszA |
Pparg bound to partial agonist h3b-487 |
|
4
|
18
|
7rleB |
Crystal structure of ppar gamma in complex with creb-binding protein and agonist gw1929 |
|
96
|
271
|
7rleA |
Crystal structure of ppar gamma in complex with creb-binding protein and agonist gw1929 |
|
2
|
11
|
7cxhB |
The ligand-free structure of human ppargamma lbd q286e mutant in the presence of the src-1 coactivator peptide |
|
104
|
274
|
7cxhA |
The ligand-free structure of human ppargamma lbd q286e mutant in the presence of the src-1 coactivator peptide |
|
98
|
273
|
7cxkA |
The ligand-free structure of human ppargamma lbd r288h mutant in the presence of the src-1 coactivator peptide |
|
99
|
273
|
7cxeA |
The ligand-free structure of human ppargamma lbd r280c mutant |
|
94
|
270
|
7cxjA |
The ligand-free structure of human ppargamma lbd r288c mutant in the presence of the src-1 coactivator peptide |
|
92
|
271
|
7cxlA |
The ligand-free structure of human ppargamma lbd s289c mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxfB |
The ligand-free structure of human ppargamma lbd c285y mutant in the presence of the src-1 coactivator peptide |
|
101
|
273
|
7cxgA |
The ligand-free structure of human ppargamma lbd q286e mutant |
|
103
|
272
|
7cxfA |
The ligand-free structure of human ppargamma lbd c285y mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxkB |
The ligand-free structure of human ppargamma lbd r288h mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxiB |
The ligand-free structure of human ppargamma lbd f287y mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxlB |
The ligand-free structure of human ppargamma lbd s289c mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxjB |
The ligand-free structure of human ppargamma lbd r288c mutant in the presence of the src-1 coactivator peptide |
|
96
|
271
|
7cxiA |
The ligand-free structure of human ppargamma lbd f287y mutant in the presence of the src-1 coactivator peptide |
|
91
|
275
|
7a7hA |
Crystal structure of ppargamma in complex with compound tk90 |
|
97
|
268
|
7efqA |
Crystal structure of hppargamma ligand binding domain complexed with rosiglitazone-based fluorescence probe |
|
101
|
276
|
6t1sA |
Ppar mutant |
|
1
|
10
|
6t1vC |
Pparg mutant |
|
99
|
268
|
6t1vA |
Pparg mutant |
|
92
|
269
|
7lotA |
Human ppar gamma lbd in complex with tetrazole compound n-{3-[(4-methylbenzyl)oxy]benzyl}-2h-tetrazol-5-amine. |
|
97
|
269
|
6vznA |
Crystal structure of human ppargamma ligand binding domain y473e mutant |
|
94
|
268
|
6vzmA |
Crystal structure of human ppargamma ligand binding domain y473e mutant in complex with darglitazone |
|
95
|
268
|
6vzlA |
Crystal structure of human ppargamma ligand binding domain in complex with gw1929 |
|
93
|
268
|
7jqgA |
Crystal structure of human ppargamma ligand binding domain y473e mutant in complex with gw1929 |
|
94
|
270
|
6vzoA |
Crystal structure of human ppargamma ligand binding domain (protein delipidated by denature and refold) |
